When you come to a fork in the road, take it!

The Lancet Diabetes and Endocrinology

Volumn 3, Issue 1, 2015, Pages 2-3

  Russell, Steven J ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CARBOHYDRATE; GLUCAGON; GLUCOSE; INSULIN; ANTIDIABETIC AGENT;

ALGORITHM; CONTINUOUS INFUSION; GLUCOSE BLOOD LEVEL; GLYCEMIC CONTROL; HUMAN; HYPERGLYCEMIA; HYPOGLYCEMIA; INSULIN PUMP; INSULIN TREATMENT; NOTE; PRIORITY JOURNAL; ARTIFICIAL PANCREAS; DIABETES MELLITUS, TYPE 1;

DIABETES MELLITUS, TYPE 1; GLUCAGON; HUMANS; HYPOGLYCEMIA; HYPOGLYCEMIC AGENTS; INSULIN; PANCREAS, ARTIFICIAL;

EID: 84949122284     PISSN: 22138587     EISSN: 22138595     Source Type: Journal    
DOI: 10.1016/S2213-8587(14)70195-0     Document Type: Note

References (10)

1. Beck RW, Tamborlane WV, Bergenstal RM, Miller KM, DuBose SN, Hall CA The T1D exchange clinic registry. J Clin Endocrinol Metab 2012, 97:4383-4389.
2. Peyser T, Dassau D, Breton M, Skyler JS The artificial pancreas: current status and future prospects in the management of diabetes. Ann NY Acad Sci 2014, 1311:102-123.
3. Haidar A, Duval C, Legault L, Rabasa-Lhoret R Pharmacokinetics of insulin aspart and glucagon in type 1 diabetes during closed-loop operation. J Diabetes Sci Technol 2013, 7:1507-1512.
4. El-Khatib FH, Russell SJ, Nathan DM, Sutherlin RG, Damiano ER A bi-hormonal closed-loop blood glucose control device for type 1 diabetes. Sci Transl Med 2010, 2:27ra27.
5. Cryer PE Minireview: Glucagon in the pathogenesis of hypoglycemia and hyperglycemia in diabetes. Endocrinology 2012, 153:1039-1048.
6. Engle JM, El Youssef J, Massoud RG, Yuen KC, Kagan R, Ward WK Novel use of glucagon in a closed-loop system for prevention of hypoglycemia in type 1 diabetes. Castle JR. Diabetes Care 2010, 33:1282-1287.
7. Haidar A, Legault L, Dallaire M, et al. Glucose-responsive insulin and glucagon delivery (dual-hormone artificial pancreas) in adults with type 1 diabetes: a randomized crossover controlled trial. CMAJ 2013, 185:297-305.
8. Russell SJ, El-Khatib FH, Sinha M, et al. Outpatient glycemic control with a bionic pancreas in type 1 diabetes. New Engl J Med 2014, 371:313-325.
9. Haidar A, Legault L, Messier V, Mitre TM, Leroux C, Rabasa-Lhoret R Comparison of dual-hormone artificial pancreas, single-hormone artificial pancreas, and conventional insulin pump therapy for glycaemic control in patients with type 1 diabetes: an open-label randomised controlled crossover trial. Lancet Diabetes Endocrinol 2014, published online Nov 27. http://dx.doi.org/10.1016/S2213-8587(14)70226-8.
10. Cersosima E, Cummins MJ, Kinzell JH, et al. A phase 2 comparative safety PK/PD study of stable nonaqueous glucagon (G-Pen) vs. Lilly glucagon for treatment of severe hypo-glycemia. Diabetes 2014, 63(suppl 1A):1-LB.